The Democratic Republic of Congo has started vaccinating frontline health workers against a form of Ebola different from those targeted by previous vaccines, officials said, as the outbreak’s death toll continues to rise.
Targeting health workers
Health authorities plan to give the vaccine to around 50,000 medical and other frontline staff who are at heightened risk of exposure while treating patients. Officials say protecting health workers is a priority both to safeguard lives and to maintain essential health services during the emergency.
Clinical trial to assess the new vaccine
Some 20,000 of the vaccinated staff are being enrolled in a one-year clinical trial intended to assess the vaccine’s safety and effectiveness against this particular Ebola strain. The trial will follow participants over time to gather data on immune response and any adverse effects.
Response amid rising fatalities
The vaccination drive comes as the outbreak’s death toll climbs, underscoring the urgency of public health interventions. Authorities and partners have emphasized vaccination, surveillance and infection control measures as central to containing transmission and protecting vulnerable populations.
Questions and next steps
Health officials said the rollout and trial will provide crucial information on whether the vaccine can help control outbreaks caused by strains not covered by earlier inoculations. The results of the one-year study are expected to guide future vaccine use and preparedness strategies.